Algert Global LLC reduced its stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 12.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,205,481 shares of the company's stock after selling 175,393 shares during the quarter. Algert Global LLC owned approximately 1.95% of Phreesia worth $12,404,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the stock. Royal Bank of Canada boosted its position in Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock valued at $617,000 after acquiring an additional 16,309 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock valued at $4,090,000 after purchasing an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Phreesia by 3.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock valued at $1,599,000 after purchasing an additional 2,158 shares in the last quarter. NewEdge Advisors LLC boosted its position in shares of Phreesia by 262.7% during the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock valued at $395,000 after purchasing an additional 11,181 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Phreesia by 0.4% in the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after purchasing an additional 2,402 shares during the period. 92.10% of the stock is currently owned by institutional investors.
Phreesia Price Performance
Shares of NYSE:PHR opened at $11.50 on Wednesday. The business has a fifty day moving average price of $10.88 and a 200-day moving average price of $10.49. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market capitalization of $710.75 million, a PE ratio of 76.66 and a beta of 0.85. Phreesia, Inc. has a 1-year low of $7.77 and a 1-year high of $32.76.
Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The business had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. Phreesia's revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned ($0.07) EPS. As a group, equities analysts expect that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the company. Citigroup reiterated a "market perform" rating on shares of Phreesia in a report on Friday, May 29th. Wells Fargo & Company restated an "equal weight" rating and set a $9.00 target price (down from $15.00) on shares of Phreesia in a report on Wednesday, May 20th. Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Saturday, May 30th. Weiss Ratings upgraded shares of Phreesia from a "sell (d)" rating to a "sell (d+)" rating in a research note on Monday, July 20th. Finally, Barclays reissued an "equal weight" rating and set a $10.00 price target (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Nine equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Phreesia currently has an average rating of "Hold" and a consensus target price of $16.65.
Check Out Our Latest Report on PHR
Phreesia Company Profile
(
Free Report)
Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
